Wound infection due to Absidiacorymbifera and Candida albicans with fatal outcome

References

• Dannaoui E, Meletiadis J, Mouton JW, Meis JF, Verweij PE. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 2003; 51: 45–52.
   Google Scholar
• De Hoog GS, Guarro J, Gene J, Figueras MJ, eds. Atlas Of Clinical Fungi, 2nd edn. Utrecht, The Netherlands: Centraalbur-eau voor Schimmelcultures and Reus, Spain: Universitat Rovira i Virgili, 2000.
   Google Scholar
• Gonzalez A, Del Palacio A, Cuetara MS, Gomez C, Carabias E, Malo Q. Zygomycosis: review of 16 cases. Enferm Infec Microbiol Clin 1996; 14: 233–239.
   Google Scholar
• Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000; 13: 236–301.
   PubMed Web of Science ®Google Scholar
• Eucker J, Sezer 0, Graf B, Possinger K. Mucormycoses. Mycoses 2001; 44: 253–260.
   PubMed Web of Science ®Google Scholar
• Anonymous. Mucormycosis. Ann Intern Med 1980; 93: 93–108.
   Google Scholar
• Chandler FW, JC Watts, eds. Pathologic diagnosis of fungal infections. Chicago: ASCP Press, 1987; 85–95.
   Google Scholar
• Sugar AM. Agents of mucormycosis and related species. In: Mandell GI, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases. New York: Churchill Livingstone, 1995: 2311 —2321.
   Google Scholar
• Jantunen E, Ruutu P, Niskanen L, Volin L, Parkkali T, Koukila-Kahkola P, Ruutu T. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant 1997; 19: 801–808.
   Google Scholar
• Leong KW, Crowley B, White B, Crotty GM, O'Brian DS, Keane C, McCann SR. Cutaneous mucormycosis due to Absidia corymbifera occurring after bone marrow transplantation. Bone Marrow Transplant 1997; 19: 513–515.
   PubMedGoogle Scholar
• MacDonald ML, Weiss PJ, Deloach-Banta LJ, Comer SW Primary cutaneous mucormycosis with a Mucor species: is iron overload a factor? Cutis 1994; 54: 275–278.
   Google Scholar
• McNab AA, McKelvie P. Iron overload is a risk factor for zygomycosis. Arch Ophthalmol 1997; 115: 919–921.
   PubMedGoogle Scholar
• Nosari A, Oreste P, Montillo M, Carrafiello G, Draisci M, Muti G, Molteni A, Morra E. Mucormycosis in hematologic malig-nancies: an emerging fungal infection. Haematologica 2000; 85: 1068–1071.
   PubMed Web of Science ®Google Scholar
• Gordon G, Indeck M, Bross J, Kapoor DA, Brotman S. Injury from silage wagon accident complicated by mucormycosis. J Trauma 1988; 28: 866–867.
   Google Scholar
• Stas KJ, Louwagie PG, Van Damme BJ, Coosemans W, Waer M, Vanrenterghem YE. Isolated zygomycosis in a bought living unrelated kidney transplant. Transpl Int 1996; 9: 600–602.
   Google Scholar
• Viscoli C, Dodi F, Pellicci E, Ardizzone G, Soro 0, Ceppa P, Nigro A, Rizzo F, Valente U. Staphylococcus aureus bacteraemia, Absidia corymbifera infection and probable pulmonary aspergil-losis in a recipient of orthotopic liver transplantation for end stage liver disease secondary to hepatitis. C J Infect 1997; 34: 281–283.
   Google Scholar
• Andrews PA, Abbs IA, Koffman CG, Ogg CS, Williams DG. Mucormycosis in transplant recipients: possible case—case trans-mission and potentiation by cytomegalovirus. Nephrol Dial Transplant 1994; 9: 1194–1196.
   Google Scholar
• Torres-Rodriguez JM, Lowinger M, Corominas JM, Madrenys N, Saballs P. Renal infection due to Absidia corymbifera in an AIDS patient. Mycoses 1993; 36: 255–258.
   Google Scholar
• Cloughley R, Kelehan J, Corbett-Feeney G, Murray M, Call-aghan J, Regan P, Cormican M. Soft tissue infection with Absidia corymbifera in a patient with idiopathic aplastic anemia. J Clin Microbiol 2002; 40: 725–727.
   Google Scholar
• Wieden MA, Steinbronn KK, Padhye AA, Ajello L, Chandler FW. Zygomycosis caused by Apophysomyces elegans. J Clin Microbiol 1985; 22: 522–526.
   PubMedGoogle Scholar
• Espinel-Ingroff A, Oakley LA, Kerkering TM. Opportunistic zygomycotic infections. A literature review Mycopathologia 1987; 97: 33–41.
   Google Scholar
• Artis WM, Fountain JA, Delcher HK, Jones HE. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transfer-rin and iron availability. Diabetes 1982; 31: 1109–1114.
   PubMed Web of Science ®Google Scholar
• Corbel MJ, Eades SM. Experimental mucormycosis in congeni-tally athymic (nude) mice. Mycopathologia 1977; 62: 117–120.
   Google Scholar
• Sugar AM. Mucormycosis. Clin Infect Dis 1992; 14\(Suppl. 1): 126–129.
   Google Scholar
• Christenson JC, Shalit I, Welch DF, Guruswamy A, Marks MI. Synergistic action of amphotericin B and rifampin against Rhizopus species. Ant imicrob Agents Chemother 1987; 31: 1775 — 1778.
   Google Scholar
• Morrison VA, McGlave PB. Mucormycosis in the BMT popula-tion. Bone Marrow Transplant 1993; 11: 383–388.
   PubMed Web of Science ®Google Scholar
• Ryan M, Yeo S, Maguire A, Webb D, O'Marcaigh A, McDermott M, Butler K, O'Meara A. Rhinocerebral zygomycosis in child-hood acute lymphoblastic leukaemia. Eur J Pediatr 2001; 160: 235–238.
   Google Scholar
• Scalise A, Barchiesi F, Viviani MA, Arzeni D, Bertani A, Scalise G. Infection due to Absidia corymbifera in a patient with a massive crush trauma of the foot. J Infect 1999; 38: 191–192.
   PubMedGoogle Scholar
• Koszyca B, Ellis D, Toogood I, Byard RW. Fluconazole in the treatment of pulmonary zygomycosis. Mycoses 1995; 38: 277–280.
   Google Scholar
• Kocak R, Tetiker T, Kocak M, Baslamisli F, Zorludemir S, Gonlusen G. Fluconazole in the treatment of three cases of mucormycosis. Eur J Clin Microbiol Infect Dis 1995; 14: 559–561.
   Google Scholar
• Sun QN, Najvar UK, Bocanegra R, Loebenberg D, Graybill JR. In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model. Ant imicrob Agents Chemother 2002; 46: 2310–2312.
   Google Scholar
• Jacobs P, Wood L, Du Toit A, Esterhuizen K. Eradication of invasive mucormycosis —effectiveness of the echinocandin FK463. Hematology 2003; 8: 119–123.
   PubMedGoogle Scholar
• Herbrecht R, Letscher—Bru V, Bowden RA, Kusne S, Anaissie EJ, Graybill JR, Noskin GA, Oppenheim AE, Pietrelli LA. Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion. Eur J Clin Microbiol Infect Dis 2001; 20: 460–466.
   PubMed Web of Science ®Google Scholar